30% Of AI Pilots For Health Care Reach Production 

About 30% of artificial intelligence (AI) pilots intended for health care applications reach production, based on a recent survey conducted by Bessemer Venture Partners, Bain & Company, and Amazon Web Services. The survey respondents said that security, data readiness, integration costs, and limited in-house expertise affected whether a pilot reached production. However, 80% of surveyed leaders across the more than 400 included health care payers, provider organizations, and pharmaceutical companies said they believe that generative AI (GenAI) will transform clinical decision-making in the near future.

GenAI is an AI platform that creates new text, images, and videos based . . .